News Hub | News Direct

Lifestyle

Beverage: Coffee/Tea/Non-Alcoholic Beverage: Spirits/Beer/Wine Casino/Gaming Fashion Food/Cooking/Baking Health & Fitness Home Goods Hospitality Leisure Activities & Hobbies Parenting Pets Photography Seniors Travel & Tourism
Article thumbnail News Release

Notable Live Announces Partnership with NFL and Tennessee Titans Great, Chris “CJ2K” Johnson

Notable Live

Notable Live, a digital platform that facilitates exceptional fan experiences is today announcing that former NFL and Tennessee Titans running back Chris “CJ2K” Johnson has joined its team as a brand ambassador focused on athlete relations and outreach. Johnson joins the Notable Live team to introduce athletes to the platform and encourage current and former athletes to extend the fan experience beyond the playing field through in-person and virtual events, e-commerce offerings, and curated fan experiences. “Over the past year I’ve developed a meaningful relationship with the Notable Live team to connect with my fans, build a community, and help my legacy live on by sharing items from my playing days with my fans,” said Johnson. “I look forward to growing my relationship with Notable Live and sharing with some of my former teammates and colleagues the unique opportunity the platform provides.” “This is an exciting day for Notable Live. From day one, Chris utilized the Notable Live platform to create unique activation opportunities for his fans and quickly became an asset to our company,” said Mike Antonucci, co-founder and CEO of Notable Live. “We are thrilled to expand our relationship with Chris as a former player and now power user of the platform,” said Antonucci. “We look forward to what we can accomplish together and remain focused on bringing new and unique opportunities to the Notable Live community.” Fans can browse and bid on current inventory from Johnson and other NFL legends in the Notable Live on eBay Store ( https://www.ebay.com/str/notablelive ). About Notable Live Notable Live was co-founded in 2018 by fan Mike Antonucci and NFL Hall of Fame player Emmitt Smith to create a unique platform providing fans with unparalleled access to their favorite notables via virtual interactive events, in-person experiences, and curated e-commerce offerings. Notable Live has a mobile app available on the App Store and Google Play that puts fans “in the room” with their favorite notables for memorable virtual experiences. Connect with Notable Live at www.notable.live or on Instagram, Facebook or Twitter. Contact Details Notable Live Shannon Gross +1 318-537-2967 shannon.gross@notable.live Company Website https://www.notable.live/

August 14, 2024 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Safety Shot, Inc. (NASDAQ: SHOT): Upside Confirmed by Scientific Research

CGR-SHOT

As the wellness industry evolves, there is increasing interest in products that address specific consumer needs beyond traditional health solutions. One area with limited innovation has been managing the effects of alcohol consumption. Safety Shot, Inc. (Nasdaq: SHOT) is making strides in this space with its flagship drink. Safety Shot is a patented beverage designed to lower blood alcohol content (BAC) by accelerating alcohol metabolism. It also aims to enhance clarity, energy, and mood. Backed by recent scientific research and expanding its distribution network, Safety Shot is positioning itself as a key tool for responsible alcohol consumption. Scientific Backing of Safety Shot The foundation of Safety Shot’s market proposition is its scientific validation, supported by significant results from a clinical trial conducted by the Center for Applied Health Sciences (CAHS) and announced on August 12, 2024. This double-blind, randomized, placebo-controlled study demonstrated the product's effectiveness in reducing BAC. Participants aged 24 to 46, with varying body weights, showed a dramatic reduction in BAC, with some experiencing rates that dropped 30%–50% faster than the placebo group. Key findings included consistent reductions in both breath and blood alcohol content, enhanced energy levels, and improved concentration. Participants also reported less head discomfort and fatigue, further substantiating the product's claims. Chief Operations Officer and co-inventor David Sandler highlighted, “These results are revolutionizing the wellness space as we continue to pioneer the world’s most innovative functional beverages.” Dr. Tim Ziegenfuss, CEO of CAHS, echoed this sentiment: “These results are highly encouraging, showcasing Safety Shot’s potential as a beneficial supplement for individuals consuming alcohol.” Expansion Through Partnerships Safety Shot, Inc. has pursued expansion through strategic partnerships, significantly enhancing its market reach. In early June, the company announced their partnership with Mr. Checkout, a national network of independent distributors and grocery distributors. This collaboration aims to introduce Safety Shot to over 200,000 independent retail locations across the U.S., leveraging Mr. Checkout’s expertise in launching and scaling innovative products. Chief Revenue Officer Josh Wagner expressed optimism about the partnership: “This is a significant step forward in exploring new verticals of accessibility for our revolutionary product. We are confident that with Mr. Checkout’s support, we will be able to expand Safety Shot’s presence into diversified retailers to meet our customers where they prefer to shop.” Expanding in New York and New Jersey Furthering its expansion efforts, Safety Shot partnered with Prime CSB, a boutique broker with a strong presence in New York and New Jersey, to enhance its footprint in these key markets. Prime CSB’s personalized distribution approach is expected to help Safety Shot gain a solid foothold in these regions, particularly as demand surges during the peak summer season. Pharmacy Integration with Capital Drugs Safety Shot’s distribution efforts extend into the pharmacy sector through a deal with Capital Drugs, placing its product in 300 pharmacies nationwide. This partnership aligns Safety Shot with its wellness mission, allowing it to reach a like-minded consumer base that frequents pharmacies for health and wellness products. Northeast Presence via Atlantic Beverage Distributors To further bolster its market presence in the Northeast, Safety Shot partnered with Atlantic Beverage Distributors, a key player in Massachusetts and Rhode Island’s beverage markets. This collaboration is expected to significantly enhance Safety Shot’s presence in the region, thanks to Atlantic Beverage Distributors’ deep understanding of the market and extensive distribution network. Wagner noted, “Their expertise in the beverage and spirits industry and dedication to working with specialty products align perfectly with where we want to take Safety Shot as we continue to grow and expand.” Nationwide Reach with KeHE Distributors The company’s nationwide expansion strategy received a significant boost through a partnership with KeHE Distributors, a leading distributor of natural and organic products in North America. This alliance is expected to bring Safety Shot to thousands of new retail locations across the country, capitalizing on KeHE’s vast distribution network. Conclusion With robust scientific evidence and a series of strategic partnerships, Safety Shot, Inc. is poised to become a leader in the wellness and dietary supplement industries. As it continues to disrupt the market and redefine responsible alcohol consumption, investors may want to be closely watching its progress. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 Mark@razorpitch.com Company Website http://razorpitch.com

August 13, 2024 06:00 AM Eastern Daylight Time

Article thumbnail News Release

K3 Holdings and Alpine LA Properties Congratulate Team USA for Winning Paris Olympics Medal Count

K3 Holdings

K3 Holdings, a privately held real estate investment firm with extensive holdings throughout the United States and Alpine LA Properties, a leasing company providing newly remodeled apartments at affordable rates in Los Angeles, congratulated Team USA for their outstanding performance in the Paris Olympics. Following more than two weeks of competition and lifetimes of preparation, athletes representing the United States won 126 medals (40 gold) leading all other countries at the conclusion of the games in Paris. "Congratulations to Team USA for showcasing the true spirit of excellence and determination, bringing home the most medals and making us all proud,” stated Michael Kadisha, a Principal of K3 Holdings. "Winning the most medals is a triumph of skill and perseverance, and more so, a testament to the unity and resilience that define the American spirit. Dedication, hard work, and a never-give-up attitude leads to greatness, and we are all inspired by the performance of our athletes in Paris.” "In sports, as in life, the way we handle victory says as much about us as the victory itself. Gratitude and humility elevate every achievement. Winning with grace and losing with dignity are the hallmarks of true champions,” Michael Kadisha continued. “The K3 Holdings and Alpine teams were impressed at how Team USA proved themselves to be real winners by celebrating their victories while honoring their opponents with respect and gratitude.” The Olympics serve as a unique platform where nations from every corner of the globe come together in a spirit of friendly competition. Beyond the medals and records, the Olympics foster an environment where cultural exchange and mutual understanding thrive. In a world often divided by differences, the Olympics create a space where adversaries can engage in dialogue, learn from one another, and find common ground through shared values of sportsmanship and respect. "The Olympics is a powerful testament to how people from diverse cultures and backgrounds can come together to achieve greatness," stated Nathan Kadisha, a K3 Principal. "The actions of Olympic athletes in Paris show us that dedication, perseverance, and mutual respect transcend borders and ideologies. These are the values that can truly unite us and drive real change beyond the games." “We are excited that Los Angeles will be hosting the Olympics four years from now,” Michael Kadisha said. “By watching athletes from rival nations compete with honor and integrity, in our own community, we will once again be reminded that even in competition, there is room for cooperation, empathy, and the possibility of resolving conflicts peacefully.” ### For more information or to schedule an interview with a K3 spokesperson, please contact Dan Rene at 202-329-8357 or dan@danrene.com Contact Details K3 Holdings/Alpine LA Properties Dan Rene +1 202-329-8357 dan@danrene.com Company Website https://k3holdings.com/

August 12, 2024 11:30 AM Eastern Daylight Time

Article thumbnail News Release

Revenue Management Solutions Named “Best Use of Research and Surveys” In PR Daily’s 2024 Social Media, Digital & Content Marketing Awards

Revenue Management Solutions

Revenue Management Solutions (RMS), a global leader in data-driven analytics and tech-enabled solutions for the restaurant industry, proudly announces its win at the 2024 Social Media, Digital & Content Marketing Awards, presented by PR Daily. For its impactful Restaurant Trend Reports, RMS took home the award in the "Use of Research/Surveys" category. The awards ceremony, held on August 1 at the prestigious Yale Club in New York City, celebrated the hidden stars and talents behind impressive social and content marketing campaigns. Attendees gathered to honor professionals across various categories, from Best Social Media Campaign to Digital Community Engagement. "Winning this award is a testament to our team's dedication and expertise in delivering insightful content that drives restaurant industry success," said Jana Zschieschang, RMS Chief Brand Officer. “Thousands of restaurant industry influencers access our Quick-Service Trend Report every month to gain clear and concise insights to navigate the ever-changing landscape of the restaurant business." RMS launched its QSR Trend Reports during the pandemic, a time of rapid change for the restaurant industry. What began as a tool to condense and simplify fast-food trends has evolved into a respected source for restaurant pricing, sales and traffic referenced by clients and leading news outlets, including Reuters, The Wall Street Journal, Bloomberg and trusted restaurant trade publications. PR Daily's Content Marketing Awards spotlight the most impactful and innovative work in the field. Brendan Gannon, Senior Marketing Manager for the Ragan/PR Daily Awards programs, praised RMS for their creative approach, noting “The winners set a new standard in content creation with exceptional storytelling and strategic insights. Their work exemplifies the power of data-driven content in capturing audience attention and driving meaningful results." As RMS celebrates this significant achievement, it continues to lead the industry in data-driven tech solutions that empower restaurant brands to confidently navigate challenges such as inflation and labor costs. For 30 years, Revenue Management Solutions has partnered with restaurant brands to deliver actionable insights and data-driven recommendations that boost sales, streamline costs, and maximize profitability. Their AI-powered solutions support over 100,000 locations worldwide, enabling brands to unlock the power of their data and thrive in a competitive market. About Revenue Management Solutions Revenue Management Solutions (RMS) partners with restaurant brands to provide data-driven solutions that drive sales, streamline costs, and enhance profitability. With AI-powered analytics, RMS supports over 100,000 locations globally, empowering brands to navigate industry challenges confidently. For more information, visit www.revenuemanage.com. About Ragan Communications and PR Daily Ragan Communications has been a trusted source of news, training, and intelligence for more than 50 years, serving internal and external communicators and business executives. PRDaily.com and Ragan.com are read by over 600,000 communicators monthly, providing insights and resources across various communication fields. Contact Details Tracy Henderson +1 720-989-3530 tracy@centerreachcommunication.com Company Website https://www.revenuemanage.com

August 12, 2024 08:33 AM Eastern Daylight Time

Article thumbnail News Release

Canada’s Gift Baskets Unveils New Line of Corporate Gift Baskets

Rev Up Marketers

Canada’s Gift Baskets is excited to announce the launch of its new line of corporate gift baskets, designed to enhance business relationships and recognize employee achievements. The new collection, available now, features a variety of high-quality, customizable gift baskets suitable for any corporate occasion. The corporate gift baskets from Canada’s Gift Baskets offer a sophisticated selection of gourmet treats, luxury items, and customizable options to cater to the unique needs of businesses. These baskets are perfect for client appreciation, employee recognition, corporate events, and holiday gifts. "We understand the importance of making a lasting impression in the business world," said Paul Dolabjian, CEO of Canada’s Gift Baskets. "Our new corporate gift baskets are curated with premium products and are customizable to reflect the values and branding of any company." Key features of the new corporate gift basket line include: Premium Quality Customization Options Variety of Choices Nationwide Delivery Canada’s Gift Baskets is committed to providing exceptional service and high-quality products. The launch of the new corporate gift baskets line underscores the company’s dedication to helping businesses build and maintain strong professional relationships. For more information about the new corporate gift baskets, visit Canada’s Gift Baskets. About Canada’s Gift Baskets Canada's Gift Baskets is a leading provider of premium gift baskets and hampers, renowned for its dedication to quality, creativity, and customer satisfaction. Based in Toronto, ON, Canada, the company has been serving customers across the nation for over a decade, offering a diverse range of beautifully curated gift baskets for every occasion, from personal celebrations to corporate events. Canada’s Gift Baskets has earned a reputation for its exceptional service, from the meticulous creation of each gift basket to the reliable and timely delivery. Whether it’s for a holiday, a milestone celebration, or to strengthen business relationships, Canada’s Gift Baskets offers the perfect solution for all gifting needs. With the launch of its new corporate gift basket line, Canada’s Gift Baskets continues to demonstrate its leadership in the industry, offering businesses across Canada a sophisticated and customizable way to show appreciation and recognize achievements. Contact Details Canada Gift Baskets Paul Dolabjian contact@canadasgiftbaskets.ca Company Website https://canadasgiftbaskets.ca/

August 09, 2024 06:33 AM Eastern Daylight Time

Image
Article thumbnail Digital Asset Direct

Back to School Ready 2024

News Media Group, Inc.

Contact Details News Media Group, Inc. Karl Wayne +1 334-440-6397 karl@newsmg.com Company Website https://newsmg.com/

August 08, 2024 01:33 PM Eastern Daylight Time

Video
Article thumbnail News Release

THE WORLD’S FIRST IMMERSIVE GAMING EXPERIENCE TO LAUNCH SECOND HOUSTON LOCATION THIS AUGUST

Activate

Activate, the pioneering live-action gaming venue and viral sensation on TikTok, is thrilled to announce the grand opening of its second location in Houston on August 16, 2024, after a successful opening in Katy. This unique and dynamic venue offers guests the chance to immerse themselves in the nationwide gaming phenomenon. Activate The Woodlands is located at 536 Sawdust Rd, Suite C, Spring, TX 77380. Activate is revolutionizing the gaming landscape, extending its reach across the United States with 40 successful locations worldwide and an unstoppable momentum. Boasting a global player base of over 2.5 million, this exciting experience combines cutting-edge technology with thrilling challenges, providing an electrifying social adventure. "Activate is excited to expand its footprint by opening a second location in Houston to meet the growing demand for immersive, interactive experiences among residents and visitors,” says Will Gray, Director of Marketing at Activate. "This new venue will allow a broader audience to experience the unique mix of physical activity and digital gaming that Activate is known for. We're excited to bring this thrill to a new market and engage more adventurers.” From August 23 to 25, Activate is hosting its Grand Opening Weekend with special surprises, the likes of which they have never done before. The new venue will offer a broader audience the opportunity to enjoy the unique blend of physical activity and digital gaming that Activate is renowned for. Activate The Woodland's cutting-edge gaming facility invites players of all ages and skill levels to explore and create their own unique gaming experiences. Here’s what to expect: Guests can sign up in groups of two to five players Through progress tracking via Activate’s high-tech electronic RFID wristbands, players can rack up points, leveling up and earning prizes along the way. Top gaming rooms include the TikTok viral sensation Mega Grid with 500+ multi-activated rainbow-coloured tiles, blasting the beaming bullseye in a game called Strike, and feel like a modern day spy in the Laser room. Try Level 1 easy or take it to Level 10 extreme. Play as a team in cooperative mode, or challenge your friends in competitive mode games. Additional Activate locations are set to open in 2024 across the U.S. in markets such as Columbus, Detroit, St. Louis, a third location in the Dallas Fort Worth Metroplex, Cleveland, and New York City, along with internationally in the UK and UAE. Today, Activate operates over 40 locations across Canada and the U.S. PLAN YOUR VISIT Wear activewear and flat, closed-toe shoes. Where: 536 Sawdust Rd., Suite C, Spring, TX 77380. When: Monday through Thursday, 10 a.m. to 10 p.m. | Friday, 10 a.m to 11 p.m | Saturday, 9 a.m. to 11 p.m. | Sunday, 9 a.m. to 10 p.m. Cost: Starting at 19.99 per player Mon-Thurs and 24.99 per player Fri-Sun (And Holidays) For a sneak peek into Activate’s action-packed gaming experience, click here. Click here for high-res assets ### Activate is the world's first active gaming experience where players #EnterTheGame. Activate offers a unique blend of physical activity and gaming that promotes a healthy lifestyle. Each Activate location provides fun and interactive rooms for players to compete, earn stars and track achievements. With the global headquarters located in Winnipeg, Canada, Activate has grown to 40 locations across Canada, and the U.S. To join the active gaming movement, visit Activate and follow on social media: Facebook: Activate Instagram: @activategames TikTok: @activategames Contact Details Jive PR + Digital Jalila Singerff +1 613-614-6777 jalila@jiveprdigital.com Company Website https://playactivate.com

August 08, 2024 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of AL001 involving Patients with Bipolar Disorder and Alzheimer's Disease

MarketJar

Mental health issues are on the rise, affecting almost 60 million US adults and more than 970 million people worldwide. 1 Rising cases has led to an uptick in new treatments moving through the clinical stages, including Alzamend Neuro, Inc. (NASDAQ:ALZN), which is focused on developing next-generation treatments for Alzheimer’s disease, bipolar disorder (BD), major depressive disorder (MDD), and post-traumatic stress disorder (PTSD). Among its promising pipeline, AL001 stands out as a potential game-changer for bipolar disorder treatment. Alzamend Neuro 's AL001, a patented ionic cocrystal technology, aims to deliver lithium in a way that reduces toxicity while maintaining therapeutic efficacy by combining lithium, salicylate, and L-proline. Alzamend Neuro is rapidly advancing treatments for mental health disorders, potentially accelerating clinical phase progress due to the successes of AL001 in a Phase I and Phase IIA clinical trials for the treatment of Alzheimer’s. In 2023, the company filed IND applications for Phase IIA Clinical Trials of AL001 for Bipolar Disorder, MDD and PTSD. By the end of 2023, the FDA granted approval for these studies via “Study may proceed” letters. Alzamend Neuro Partners with MGH for Phase II Trial of Next-Generation Lithium Therapeutic Drug Candidate for Bipolar Disorder On August 6th, Alzamend Neuro, Inc. (NASDAQ:ALZN) announced a partnership with Massachusetts General Hospital (MGH) to conduct a Phase II clinical trial of AL001 for treatment of patients with bipolar disorder. MGH, the primary clinical education and research facility of Harvard Medical School, is the world's largest hospital-based research program. Dr. Ovidiu Andronesi MD, PhD, Associate Professor of Radiology at Harvard University and Director of Multinuclear Metabolic Imaging at the Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, will lead the study as the Principal Investigator. The trial will compare AL001 to a marketed lithium carbonate product, focusing on bioavailability and brain distribution of lithium, with the goal of establishing AL001's safe, effective, and tolerable dosing requirements. AL001 is designed to offer the therapeutic benefits of traditional lithium salts while minimizing their toxic side effects. This head-to-head study will measure lithium levels in the brain and structures of bipolar disorder patients, building on mouse studies that suggest AL001 can achieve therapeutic benefits at lower doses. The study will also leverage brain imaging to predict the efficacy and safety of AL001 compared to existing lithium treatments. Alzamend Neuro 's previous Phase IIA studies of AL001 in Alzheimer's patients and healthy subjects have demonstrated a benign safety profile, identifying a candidate dose unlikely to require therapeutic drug monitoring (TDM). This is a significant advancement, as current lithium treatments require rigorous monitoring due to their narrow therapeutic window and potential toxicity. “We are elated to partner with Massachusetts General Hospital and Dr. Andronesi in this pivotal study for our lead therapeutic candidate AL001,” said Alzamend Neuro, Inc. (NASDAQ:ALZN) CEO Stephan Jackman, “If we can develop a next-generation lithium product (AL001) with an improved safety profile and enhanced biodistribution in the brain that would not routinely require therapeutic drug monitoring (TDM), it would constitute a major improvement over current lithium-based treatments and positively impact the 7+ million Americans afflicted with bipolar disorder. We look forward to providing more details regarding study timelines and market opportunity in the near future.” This innovation has the potential to positively impact the over 7 million Americans living with bipolar disorder. Further details about the study timelines and market potential will be shared soon. Alzamend Neuro to Conduct a Phase II Clinical Trial of AL001, involving Patients with Alzheimer’s Disease Alzamend Neuro, Inc. (NASDAQ:ALZN) also just announced a collaboration with Massachusetts General Hospital (MGH) to conduct A Phase II clinical trial for AL001, for the potential treatment of Alzheimer's disease. This trial will involve both Alzheimer’s patients and healthy subjects to compare the bioavailability and brain distribution of AL001 versus a marketed lithium carbonate product. The trial, which will also be led by Dr. Ovidiu Andronesi of Harvard University, aim to establish AL001's safe, effective, and tolerable dosing requirements. The potential to avoid the need for therapeutic drug monitoring (TDM) is also significant, as it could simplify treatment regimens and improve patient compliance. By potentially offering a safer and more effective alternative to traditional lithium treatments, AL001 could revolutionize how Alzheimer's disease is managed. The ability to measure lithium levels directly in the brain and brain structures using advanced imaging techniques will provide invaluable insights into the drug’s efficacy and safety. This approach not only enhances our understanding of how AL001 works but also supports its potential approval through a Section 505(b)(2) pathway with the FDA. If successful, the trial could pave the way for a new era in Alzheimer's treatment, providing hope for millions of patients and their families. Financial Support for Clinical Trial In addition to this groundbreaking partnership, Alzamend Neuro, Inc. (NASDAQ:ALZN) recently secured the first two tranches of a $25 million Series A purchasing agreement. This investment supports the advancement of Alzamend 's clinical trial and the development of next-generation treatments for Alzheimer’s, bipolar disorder, MDD, and PTSD. CEO Stephan Jackman emphasized the company's dedication to advancing clinical milestones and revolutionizing lithium-based therapies for millions affected by these conditions. Click here for more information about Alzamend Neuro, Inc. (NASDAQ:ALZN). [1] https://www.who.int/health-topics/mental-health#tab=tab_2 Disclaimer  1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.  2) The Article was issued on behalf of and sponsored by, Alzamend Neuro, Inc. Market Jar Media Inc. was paid $1,500 for the production and publishing of this article by Alzamend Neuro, Inc.’s Digital Marketing Agency of Record (Native Ads Inc.). Additional details relating to Market Jar Media Inc.’s engagement by Alzamend Neuro, Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) are set out in https://pressreach.com/disclaimer-alzn.  3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.  4) The Article does not constitute investment advice. All investments carry risk and each reader is encouraged to consult with his or her individual financial professional. Any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on pressreach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on pressreach.com.  5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.  6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management's expectations regarding Alzamend Neuro, Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Alzamend Neuro, Inc.’s industry; (b) market opportunity; (c) Alzamend Neuro, Inc.’s business plans and strategies; (d) services that Alzamend Neuro, Inc. intends to offer; (e) Alzamend Neuro, Inc.’s milestone projections and targets; (f) Alzamend Neuro, Inc.’s expectations regarding receipt of approval for regulatory applications; (g) Alzamend Neuro, Inc.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Alzamend Neuro, Inc.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Alzamend Neuro, Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Alzamend Neuro, Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Alzamend Neuro, Inc.’s ability to enter into contractual arrangements with additional parties; (e) the accuracy of budgeted costs and expenditures; (f) Alzamend Neuro, Inc.’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Alzamend Neuro, Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Alzamend Neuro, Inc.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Alzamend Neuro, Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Alzamend Neuro, Inc.’s business operations (e) Alzamend Neuro, Inc. may be unable to implement its growth strategy; and (f) increased competition.  Except as required by law, Alzamend Neuro, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Alzamend Neuro, Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Alzamend Neuro, Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document.  7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Alzamend Neuro, Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Alzamend Neuro, Inc. or such entities and are not necessarily indicative of future performance of Alzamend Neuro, Inc. or such entities.  8) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on pressreach.com constitutes advice or a recommendation. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

August 06, 2024 11:45 AM Eastern Daylight Time

Image
Article thumbnail Digital Asset Direct

What’s Cool for School 2024

News Media Group, Inc.

Contact Details Karl Wayne +1 334-440-6397 karl@newsmg.com Company Website https://newsmg.com/

August 01, 2024 01:10 PM Eastern Daylight Time

Video
1 ... 7891011 ... 324